However, knowledge of miRNA regulation of Fzd9 is limited, with only one published study showing miR-31 indirectly inhibiting Fzd9 expression and supporting cancer-promoting signaling in NSCLC in vitro and in vivo (Tennis et al., 2016). This evidence concerns the gene FZD9 and non-small cell lung carcinoma.